Region:Global
Author(s):Dev
Product Code:KRAC3475
Pages:94
Published On:October 2025

By Type:The market is segmented into Cold Chain Logistics and Non-Cold Chain Logistics. Cold Chain Logistics is crucial for transporting temperature-sensitive products such as biologics and vaccines, while Non-Cold Chain Logistics caters to standard pharmaceutical products. The expansion of cold chain services is accelerating at 5.50% CAGR due to increasing demand for temperature-controlled biologics, vaccines, and cell & gene therapies requiring temperatures from 2°C to ?196°C.

By Service:The market is segmented into Transportation, Storage, and Monitoring services. Transportation is vital for the movement of pharmaceuticals, while Storage ensures proper conditions for product integrity, and Monitoring provides real-time tracking of shipments. Transportation services account for 44.2% of market share, reflecting the sector's core requirement for global product movement.

The Global Pharmaceutical Logistics Market is characterized by a dynamic mix of regional and international players. Leading participants such as DHL Supply Chain, FedEx Corporation, UPS Healthcare, Kuehne + Nagel, DB Schenker, XPO Logistics, Cardinal Health, AmerisourceBergen, McKesson Corporation, Thermo Fisher Scientific, CEVA Logistics, C.H. Robinson, DSV Panalpina, Agility Logistics, Kintetsu World Express, Nippon Express, Sinotrans, Kerry Logistics, Bolloré Logistics, Yusen Logistics contribute to innovation, geographic expansion, and service delivery in this space.
The future of pharmaceutical logistics is poised for transformation, driven by technological advancements and evolving market demands. The integration of artificial intelligence and automation is expected to enhance operational efficiency, while the emphasis on sustainability will shape logistics practices. Additionally, the growth of e-commerce in pharmaceuticals will necessitate innovative last-mile delivery solutions, ensuring timely access to medications. As the industry adapts to these trends, logistics providers will need to invest in technology and infrastructure to remain competitive.
| Segment | Sub-Segments |
|---|---|
| By Type | Cold Chain Logistics Non-Cold Chain Logistics |
| By Service | Transportation Storage Monitoring |
| By Mode of Transportation | Road Air Sea Rail |
| By Application | Biopharma Chemical Specialty Pharma |
| By Region | North America Latin America Western Europe Eastern Europe East Asia South Asia & Pacific Middle East & Africa Russia & Belarus Central Asia Balkan & Baltic Countries |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Pharmaceutical Manufacturing Logistics | 120 | Logistics Managers, Supply Chain Executives |
| Cold Chain Distribution | 90 | Operations Managers, Quality Assurance Specialists |
| Third-Party Logistics Providers | 70 | Business Development Managers, Compliance Officers |
| Pharmaceutical Retail Logistics | 60 | Inventory Managers, Procurement Specialists |
| Regulatory Compliance in Logistics | 50 | Regulatory Affairs Managers, Legal Advisors |
The Global Pharmaceutical Logistics Market is valued at approximately USD 102.7 billion, driven by the increasing demand for temperature-sensitive pharmaceuticals and the expansion of global supply chains.